| 저자 |
Harin Rhee1, Woo Jin Jung1, Sang A Choi1, Min Ji Shin1, Byung Yoon Yang1,Ihm Soo Kwak1, Ji Young Yang2, Kyung Joo Park3, Min Ja Baek3,Keum Sook Jang3, Yeon Joo Lee3, Sun Hyae Kim3, Eun Young Seong1 |
| 초록 |
Introduction: The aim of this study was to compare mineral metabolism between anuric and non-anuric chronic
hemodialysis patients and to determine the differences in phosphate control between the two groups according to
residual renal function.
Materials and methods: A total of 77 chronic hemodialysis patients were enrolled in this cross sectional study from
January to February 2012. The patients’ demographics, laboratory findings, medication histories and vascular calcification
scores were collected. We divided the patients into anuric and non-anuric groups according to residual renal
function and then compared the clinical features. Multivariate binary regression analysis was used in each group to
determine the independent factors related to phosphate control.
Results: The mean patient age was 59.27±13.95 years old, and 57.1% of patients were anuric. In the anuric patients,
the dialysis vintage was significantly longer, but the mean Kt/V was not different between groups. Serum phosphate,
FGF-23 and Ca/P products were significantly higher, and 1.25(OH) vitamin D levels were significantly lower in the
anuric patients, although the intact PTH, 25(OH) vitamin D levels and vascular calcification scores were not different.
In the anuric patients, LnFGF-23 (HR 2.894, 95% CI 1.294-6.474, p=0.010) was the independent factor predictive
of phosphate control. However, in the non-anuric patients, GFR (HR 0.409, 95%CI 0.169-0.989, p=0.047) and BUN
(HR1.090, 95%CI 1.014-1.172, p=0.019) were the independent factors predictive of phosphate control.
Conclusion: In chronic hemodialysis patients, factors associated with phosphate control are different according to the
residual renal function status. Further study is needed to determine the mechanisms that explain the associations
between serum phosphate, FGF-23, intact PTH, 1.25(OH) vitamin D and residual renal function. |